Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,879,393 papers from all fields of science
Search
Sign In
Create Free Account
rasagiline
Known as:
(R)-Indan-1-yl-prop-2-ynyl-amine
, rasagiline [Chemical/Ingredient]
, RAS
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Narrower (6)
AGN 1135
Azilect
N-propargyl-1-aminoindan mesylate
TVP 101
Expand
Broader (3)
Indans
Monoamine Oxidase Inhibitors
Neuroprotective Agents
Rasagiline Tartrate
rasagiline 1 MG Oral Tablet [Azilect]
rasagiline mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Tea Polyphenolics and their Effect on Neurodegenerative Disorders-A Review
A. Bagchi
,
D. Swain
,
Nairanjana Bera
,
A. Mitra
2016
Corpus ID: 44185719
Tea consumption is varying its status from ancient beverage and a lifestyle habit, to a nutraceutical with possible prospective…
Expand
2016
2016
Bioequivalence between Generic Rasagiline (As Tartrate) and Rasagiline (As Mesylate)
Van Rijswick Ygj
,
Quesada Mj
,
Van Os Shg
2016
Corpus ID: 43969711
Rasagiline is a selective irreversible monoamine oxidase type B (MAO-B) inhibitor and indicated for the treatment of idiopathic…
Expand
2014
2014
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF NEWER RASAGILINE MESYLATE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM
T. SwaroopaRani
,
R. Anusha
,
M. Deepthi
,
J. Sateesh
2014
Corpus ID: 96766181
Rasagiline mesylate is a highly potent sensitive and irreversible second generation mono amino oxidase inhibitor with selectivity…
Expand
2014
2014
Quantitative EEG Changes in Patients with Parkinson's Disease during Therapy with Rasagiline
W. Dimpfel
,
C. Oehlwein
,
Josef A. Hoffmann
,
Thomas Müller
2014
Corpus ID: 9620495
It has been suggested that in patients with Parkinson’s disease (PD) metabolism of the MAO-B inhibitor selegiline to…
Expand
2012
2012
Validated RP-HPLC Method for Estimation of Rasagiline in Tablet Dosage Form
Bhavinkumar Vaishnani
,
R. Kimbahune
,
P. Kabra
,
S. Surani
,
L. Nargund
2012
Corpus ID: 124799630
In the present study, a reverse phase high performance liquid chromatographic method was developed and validated for the…
Expand
2011
2011
STABILITY INDICATING RP-HPLC METHOD FOR THE DETERMINATION OF RASAGILINE IN PHARMACEUTICAL PRODUCTS
Kullai Reddy Ulavapalli
,
J. Sriramulu
,
U. Mallu
,
V. Pyreddy
2011
Corpus ID: 96908232
Stability indicating RP-HPLC method has been developed for the determination of Rasagiline assay in pharmaceutical products…
Expand
2010
2010
Rasagilina:: eficacia y protección en la enfermedad de Parkinson
J. Pagonabarraga
,
J. Kulisevsky
2010
Corpus ID: 68058832
Introduccion. La enfermedad de Parkinson (EP) representa la segunda enfermedad neurodegenerativa mas frecuente en la poblacion…
Expand
2010
2010
Determination of Rasagiline Mesilate in Human Plasma by LC-MS/MS and Study on Its Pharmacokinetics
Ai-Dong Wen
2010
Corpus ID: 101415691
OBJECTIVE:To establish an LC-MS/MS method for the determination of rasagiline mesilate in human plasma and study its…
Expand
2009
2009
Soft Gelatin Capsules rasagiline
T. Andrýsek
,
Fanny Caciularu
,
+5 authors
Marina Zholkovsky
2009
Corpus ID: 103150860
A pharmaceutical composition comprising a liquid fill comprising an amount of derasagilina mesylate, a shell comprising gelatine…
Expand
2006
2006
Efficacy and safety of rasagiline in the treatment of Parkinson disease
R. Hauser
2006
Corpus ID: 78785183
Rasagiline was recently approved as monotherapy in early Parkinson disease (PD) and as an adjunct to levodopa in PD patients with…
Expand